The Wolverine Drug Ortho Rhode Island BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Revolutionizing Recovery: How Dr. Lundquist is Using BPC 157, TB 500, and Regenerative Therapies to Accelerate Healing Active Life Pain Center When you inject peptides like BPC 157 over the area of pain, it does not directly go to the area of tissue damage initially. The medication is absorbed by the blood vessels in the subcutaneous tissue The Future of Healing: What BPC 157 Could Mean for You, and How We Can Help Explore It Lubbock Primary Care Clinic